Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0557 in Obese Subjects
NCT00533598Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2002
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0557 in obesity, sponsored by Merck & Co.. Started Sep 2002; status: completed.
02
Drugs
MK-0557
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00533598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533598.